- Home
- VKTX vs RDN Comparison
VKTX vs RDN Comparison
Compare VKTX & RDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- RDN
- Stock Information
- Founded
- VKTX 2012
- RDN 1977
- Country
- VKTX United States
- RDN United States
- Employees
- VKTX N/A
- RDN N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- RDN Property-Casualty Insurers
- Sector
- VKTX Health Care
- RDN Finance
- Exchange
- VKTX Nasdaq
- RDN Nasdaq
- Market Cap
- VKTX 4.7B
- RDN 5.3B
- IPO Year
- VKTX 2015
- RDN 1992
- Fundamental
- Price
- VKTX $32.87
- RDN $33.34
- Analyst Decision
- VKTX Strong Buy
- RDN Buy
- Analyst Count
- VKTX 12
- RDN 5
- Target Price
- VKTX $106.75
- RDN $36.30
- AVG Volume (30 Days)
- VKTX 3.5M
- RDN 1.3M
- Earning Date
- VKTX 02-05-2025
- RDN 02-05-2025
- Dividend Yield
- VKTX N/A
- RDN 2.95%
- EPS Growth
- VKTX N/A
- RDN N/A
- EPS
- VKTX N/A
- RDN 3.86
- Revenue
- VKTX N/A
- RDN $1,303,066,000.00
- Revenue This Year
- VKTX N/A
- RDN N/A
- Revenue Next Year
- VKTX N/A
- RDN $3.15
- P/E Ratio
- VKTX N/A
- RDN $8.60
- Revenue Growth
- VKTX N/A
- RDN 6.23
- 52 Week Low
- VKTX $20.92
- RDN $26.11
- 52 Week High
- VKTX $99.41
- RDN $37.86
- Technical
- Relative Strength Index (RSI)
- VKTX 26.61
- RDN 57.60
- Support Level
- VKTX $32.51
- RDN $30.42
- Resistance Level
- VKTX $43.55
- RDN $32.41
- Average True Range (ATR)
- VKTX 2.15
- RDN 0.61
- MACD
- VKTX -0.41
- RDN 0.28
- Stochastic Oscillator
- VKTX 17.78
- RDN 95.58
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About RDN Radian Group Inc.
Radian Group Inc provides mortgage insurance and services to the real estate and mortgage finance industries. Radian's mortgage insurance provides coverage to lending institutions throughout the United States. Its services include analytics and consulting for buyers and sellers of, and investors in, mortgage- and real estate-related loans and securities and other asset-backed securities. Insurance premiums account for more than three fourths of the company's revenue. Services revenue and investment income are the other principal sources of revenue. It operates in two segments: Mortgage and homegenius. The Mortgage segment earns the majority of revenue.